Citigroup Initiates Coverage On Phibro Animal Health with Neutral Rating, Announces Price Target of $62
Benzinga Newsdesk 6 months ago
NewsPrice TargetInitiationAnalyst Ratings
Citigroup analyst Daniel Grosslight initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Neutral rating and announces Price Target of $62.
Citigroup analyst Daniel Grosslight initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Neutral rating and announces Price Target of $62.